SUPERBRANCHE : Dentritic Nanoparticles

supporting early stage diagnosis and targeted therapy

SUPERBRANCHE : Nanomedicine as a breakthrough to treat cancer

We bring answers to the following issue: intratumoral injection of nanomaterials implying both accessibility and detection of the tumor beforehand. We position ourselves as a producer dedicated to the synthesis of architectured nanomaterials as simple as possible and of controlled size.

INNOVATION

Our modular technology platform presents both therapeutic and diagnosis applications.
It consists in a magnetic nanoparticle coated by a tailor made branched architecture.

Thanks to their optimized shape and stability, our compounds are well tolerated and can be administered intravenously,
thus helping to the early detection and treatment of metastases.

The main advantage of the SUPERBRANCHE technology stem from
our specific  processes and synthesis know-how which are at the heart of our innovations.”

PRODUCTS AND TECHNOLOGIC PARTNERSHIPS

Superbranche is a Biotechnology company characterized by two main activities:

the sale of dendrimers and nanoparticles as research products to any laboratory in the field of nanomedicine

conducting development partnerships to bring to the clinics targeted diagnostic and image-guided therapy nanomaterials based on its proprietary technology.

Superbranche is a spin-off company from a CNRS – University of Strasbourg – ECPM mixed research unit which technology of dendronized magnetic nanoparticles has been validated by several hospitals
0
Years of Research
0
Proof of Concept
0
Patents

STAY TUNED

FOLLOW US ON SOCIAL NETWORKS